Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

Tool of the Month - infiniSee xREAL
July 27, 2026 10:57 CEST
This August, Trillions Fit on Your Desktop This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. Most screening campaigns are limited less by ideas than by the size of the catalog you can search. infiniSee xREAL removes that limit. It is the only...
Read on
category
Publications
New Publication: Strategies for Identifying Molecules of Interest in Large Chemical Spaces
July 14, 2026 11:25 CEST
In collaboration with Pfizer, our team recently published a study in the Journal of Chemical Information and Modeling. The work represents fundamental research into molecular similarity, extended to ultra-large, combinatorial Chemical Spaces. Read the Full Publication (Open Access) Which Central Questions Were Addressed? Which similarity-score thresholds are meaningful? How do...
Read on
category
Challenge
Dylan Capitti Fenton Wins Scientific Challenge Summer 2025!
July 13, 2026 11:50 CEST
It is our greatest pleasure to announce the winner of the Summer 2025 edition of the Scientific Challenge: the winner is Dylan Capitti Fenton of California State University, Northridge (Van Nuys, United States) with his project ‘Structure-Based Drug Discovery of Bitter Taste Receptor Agonists for GLP-1 Release’. Focusing on the...
Read on